We found that Wnt and PI3K signaling are recurrently deregulated following Nf2 loss in our mouse model, leading us to identify coinhibition of Wnt and PI3K as a potent therapeutic combination in reducing ICC growth. This evidence concerns the gene NF2 and intrahepatic cholangiocarcinoma.